Fluid balance and mortality in critically ill patients with acute kidney injury: a multicenter prospective epidemiological study

We investigated the influence of fluid balance on outcomes among critically ill patients
with AKI in a large, multicenter, observational study involving 30 ICUs. Patients
who developed AKI were older, more severely ill, and more frequently presented with
sepsis upon ICU admission than patients without AKI. The mortality rates were higher
among patients with AKI than in those without AKI, particularly in patients with oliguria.
The daily fluid balance was higher in the AKI group than in the non-AKI group. Patients
with AKI consistently had higher cumulative fluid balance at 24, 48, and 72 h following
ICU admission than patients without AKI. The cumulative fluid balance over 3 days
was significantly higher among non-surviving patients with AKI and was significantly
associated with increased 28-day mortality in patients with AKI.

The fluid balance was higher in patients with AKI. According to the multivariable
model, the presence of FO increased the incidence of AKI distinctly. However, we could
not determine the relationship between a positive fluid balance and the incidence
of AKI, because we failed to determine the fluid balance before ICU admission, which
might have influenced the incidence of AKI and outcomes. The findings of the present
study should stimulate further research to investigate the role of fluid balance on
the incidence of AKI.

In fact, several lines of evidence suggest that fluid therapy, rather than preserving
renal function, actually precipitates or worsens AKI by causing FO. Positive fluid
balance triggers AKI after cardiac surgery 29], 30]. On the contrary, the use of goal-directed therapy (GDT) strategies for perioperative
hemodynamic optimization have been associated with decreased surgical complications
31]–33] and reduced risk of postoperative AKI 34]. Prowle et al. reviewed 24 studies and found that GDT in surgery was associated with
a significantly lower incidence of AKI (OR 0.59, 95 % CI 0.39–0.89, P?=?0.013; n?=?24 studies, n?=?2763 patients) 35].

In our study, FO affected the incidence of AKI and the severity of AKI. AKI severity
increased significantly when the fluid volume was more than 10 %. The degree of FO
has also been suggested as an index of AKI severity in pediatric patients 36]. However, the cutoff value is not clear, because an elaborate ROC curve analysis
would be required.

In our study, fluid accumulation was associated with adverse outcomes in patients
with AKI, and this finding is consistent with those of prior studies. Teixeira et
al. performed a secondary analysis of data from a multicenter, prospective cohort
study in 10 Italian ICUs 28] including 601 patients. They found that mean fluid balance (MFB) was higher (P?=?0.008) in patients with AKI. When analyzing the subgroups separately by 28-day
mortality, non-survivor patients with AKI had significantly higher MFB than survivors.
In a multicenter, prospective, observational study with 296 patients from 17 ICUs,
Vaara et al. also reported that FO in renal support therapy (RST) was associated with
a higher risk of death at 90 days (OR 2.6) after adjustment for severity of illness,
RST onset time, RST modality, and sepsis 37]. The Sepsis Occurrence in Acutely Ill Patients study investigators found that FO
in septic patients with AKI was associated with higher mortality at 60 days 15]. Several other studies also showed positive fluid balance increased mortality among
ICU patients 38]–41].

The relationship of fluid accumulation and mortality associated with AKI is complex.
It is not possible to determine whether the positive fluid balance found in patients
with AKI was the cause or the result of a greater severity of illness. Perhaps there
was a higher severity of illness and hypotension among those who received more fluids,
which are well-known clinical risk factors for AKI and mortality. There are many factors
that affect the prognosis of patients with AKI, and we needed to rule out confounding
factors and perform a propensity analysis to further explore this issue.

When we stratified the patients with AKI by fluid accumulated during the first 3 days,
we found that greater fluid accumulation increased mortality among patients with AKI.
In contrast, the mortality of patients with a negative fluid balance was the lowest.
Our findings are in agreement with reports of a number of previous studies. Bouchard
et al. 17] evaluated the adult population with AKI in the PICARD study and found that, at the
time of AKI diagnosis, the percentage of fluid accumulation in relation to the patient’s
weight upon ICU admission was lower among survivors than non-survivors (P?=?0.01). When the rate of fluid accumulation of all patients was greater than 10 %,
the mortality at 30 and 60 days climbed from 25 % to 37 % (P?=?0.02) and from 35 % to 48 % (P?=?0.01), respectively. Patients who maintained fluid accumulation during their hospitalization
showed higher mortality proportional to fluid buildup (P??0.001). Vaara et al. 37] demonstrated a direct association between cumulative FO at RRT initiation and an
increased risk of 90-day mortality. Researchers in a pediatric study also found a
3 % increase in mortality for every 1 % increase in FO. Children with more than 20 %
FO had an OR for mortality of 8.5 compared with children with less than 20 % FO 42].

RRT might be effective in reducing FO and increasing survival. However, in our study,
RRT was an independent risk factor for 28-day mortality (Table 3). The mortality of patients treated with RRT was higher (see Additional file 3: Table S2). This finding may be explained partly by increased illness severity upon
ICU admission. Our findings in this regard are consistent with those of other studies
15], 43].

This study is unique in providing detailed insights into fluid balance and mortality
in critically ill patients with AKI in Beijing, China. Compared with previous studies,
we defined and classified AKI severity according to the KDIGO criteria, reducing underestimation
or late recognition of AKI. In addition, the study subjects with 3-day sequential
data included in our study may decrease selection bias, and the results are thus more
credible than in other studies. Our study provides insight into the significance of
fluid accumulation in terms of degree and duration.

However, some limitations must be considered. First, fluid balance before ICU admission
was not measured, which might influence the incidence of AKI and the outcomes. Second,
fluid gain could be the result of either overzealous fluid therapy or poor urine output;
we could not differentiate between the two components. Third, there are many factors
that affect the prognosis of patients with AKI. Fluid balance is one of these factors,
and we need to perform a propensity analysis to further explore this issue. In addition,
we failed to determine the type of fluid given (i.e., colloid versus crystalloid,
parenteral versus enteral), aside from the volume, which may have influenced outcomes.
We also excluded patients who had been in the ICU for fewer than 3 days but had more
severe illness, and our results could have been a little more meaningful if we had
included such patients.